Which sectors demonstrate the most prominent gains among hundred-yuan stocks?
The A-share market's total capitalization has surpassed the 100 trillion yuan milestone for the first time, with the hundred-yuan stock camp experiencing robust expansion.
As of August 18th closing, the number of A-share stocks priced above 100 yuan has surged to 134, nearly doubling from the 69 recorded at year-start. Among these, Cambricon Technologies Corporation Limited (688256.SH) has rallied over 40% year-to-date, briefly touching the thousand-yuan threshold during August 19th trading before settling at 933 yuan per share, positioning it as the most promising candidate to join the "thousand-yuan stock club" after Kweichow Moutai Co.,Ltd. (600519.SH).
Among these A-share "blue-chips," which industries show the strongest momentum in hundred-yuan stocks? How do current valuations compare to historical peaks? Let's examine these questions through detailed analysis.
**Hundred-Yuan Stock Count Nearly Doubles from Year-Start**
Market participants widely regard the quantity of hundred-yuan stocks (shares exceeding 100 yuan) as a crucial barometer of market sentiment, as these high-priced securities typically attract significant investor attention.
Since the year began, A-share hundred-yuan stocks have demonstrated clear expansion. As of August 18th, their count has jumped from 69 at year-start to 134, representing an almost complete doubling. Throughout this process, the hundred-yuan stock population has fluctuated notably with market movements. By late February, the count reached 90, then contracted to 67 in April during a market downturn, before gradually recovering to over 130 by late July and breaking through 134 by August 18th.
The top three hundred-yuan stocks are Kweichow Moutai Co.,Ltd., Cambricon Technologies Corporation Limited, and Hithink Royalflush Information Network Co.,Ltd. (300033.SZ), trading at 1,428.50 yuan, 950 yuan, and 404.9 yuan per share, respectively.
While Kweichow Moutai Co.,Ltd. remains the sole "thousand-yuan stock," its price has declined from 1,488 yuan at year-start to 1,428.5 yuan, representing a year-to-date drop exceeding 6.2%. Cambricon Technologies Corporation Limited has shown impressive performance, rising from 645.6 yuan at year-start to 950 yuan, gaining over 40%, with early trading on August 18th briefly surpassing the thousand-yuan mark. Hithink Royalflush Information Network Co.,Ltd. has climbed from 267.55 yuan to 404.9 yuan, also gaining over 40%.
Similar to Cambricon Technologies Corporation Limited and Hithink Royalflush Information Network Co.,Ltd., numerous stocks have experienced dramatic price surges this year, becoming newly minted high-priced "comeback stories." According to Choice data statistics, among the 134 hundred-yuan stocks, 71 first entered the hundred-yuan category in 2025.
For instance, Victory Giant Technology(Huizhou) Co.,Ltd. (300476.SZ) closed at just 41.88 yuan per share on January 2nd this year but has risen to 231.77 yuan by August 18th, representing a year-to-date gain exceeding 450% and pushing market capitalization past the 200 billion yuan threshold. The company gained prominence as the "only mainland supplier invited" to NVIDIA's annual conference in early 2025, creating strong associations with computing power concepts and attracting significant capital market attention.
Similarly, Fujian Cosunter Pharmaceutical Co.,Ltd. (300436.SZ) has experienced a standout year. The company's January 2nd closing price was merely 31.25 yuan per share, but by August 18th it had increased to 172 yuan, firmly establishing itself in the hundred-yuan category. Contrasting with Victory Giant Technology(Huizhou) Co.,Ltd.'s steady ascent, Fujian Cosunter Pharmaceutical Co.,Ltd.'s stock price exploded in July. Driven by development progress of its hepatitis B innovative drug GST-HG131 (not yet marketed), the stock surged nearly 220% that month, ranking second on the A-share monthly gains chart.
Among the 71 newly minted hundred-yuan stocks, 8 are companies that went public this year, primarily concentrated in electronics and power equipment sectors. For example, Insta360 (688755.SH) listed in June this year and closed at 269 yuan per share on August 18th, achieving a 469.7% year-to-date gain. Beijing Hyperstrong Technology Co.,Ltd. (688411.SH), which went public in January, has also achieved a 462% year-to-date gain. Ongoal Technology Co.,Ltd. (301662.SZ) and Sidea Semiconductor Equipment (Shenzhen) Co.,Ltd. (301629.SZ) both listed this year with year-to-date gains of 304.44% and 230.91%, respectively.
**Strong "Technology Flavor"**
Which industries produce the fastest-rising stocks in the new hundred-yuan camp, and what characteristics do they share?
Using year-to-date gains exceeding 200% as screening criteria, 12 stocks emerge. From an industry perspective, current hundred-yuan stocks concentrate primarily in sectors with stronger technology attributes, with limited representation from traditional industries.
Power equipment, electronics, pharmaceutical biotechnology, and defense/military sectors have become hotbeds for "high-priced stocks," with some benefiting from periodic market theme catalysts.
Take Insta360 as an example – this consumer electronics stock has experienced multiple rally phases, gaining approximately 469% year-to-date. Catalysts have provided additional momentum. On August 15th, a video of Insta360 founder Liu Jingkang distributing cash to employees circulated online, quickly sparking controversy. However, this unexpectedly boosted the company's stock price, with August 15th and 16th seeing consecutive "20cm" daily limit-ups, reaching 269.3 yuan and achieving a market cap of 108 billion yuan. Fellow electronics companies Victory Giant Technology(Huizhou) Co.,Ltd. and Dongxin Semiconductor have also achieved respective year-to-date gains of 231.77% and 103.99%, successfully joining the hundred-yuan ranks.
In pharmaceutical biotechnology, Brightgene Bio-Medical Technology Co.,Ltd. (688166.SH) gained 270.2% year-to-date based on development progress of its GLP-1/GIP dual-target weight-loss drug BGM0504, while Beijing Hotgen Biotech Co.,Ltd. (688068.SH) followed closely with 267% gains.
In defense/military sectors, Northern Longbow stands out particularly. Trading at 170.88 yuan per share on the 18th, it has gained approximately 414% year-to-date. This surge primarily stems from alignment with military concept themes. Currently, global geopolitical landscapes have entered a "high-risk, high-volatility" new phase, combined with the upcoming military parade on September 3rd, keeping defense sector sentiment continuously heated with individual stocks experiencing persistent rallies.
Regarding market capitalization distribution, the current hundred-yuan camp includes 25 stocks with market caps exceeding 100 billion yuan, 91 stocks with market caps between 10 billion and 100 billion yuan, and 18 stocks below 10 billion yuan. Overall, the hundred-yuan camp shows relatively balanced distribution across different market cap scales, with medium-scale stocks being relatively more numerous.
**Some Hundred-Yuan Stocks Approach Historical Valuation Peaks**
Currently, most hundred-yuan stocks' overall valuations have reached historical highs.
Using the formula "1-(trading day total market cap ranking among all total market caps/total trading days in selected period)" roughly estimates current individual stock market cap percentiles – higher percentile positions indicate closer proximity to historical market cap peaks. According to Choice data statistics, among hundred-yuan stocks, 81 currently have total market caps positioned above the historical 90th percentile. Only 11 stocks have total market caps below the historical 50th percentile.
Among these, 45 stocks including Hithink Royalflush Information Network Co.,Ltd., Zhongji Innolight Co.,Ltd. (300308.SZ), Hubei Feilihua Quartz Glass Co.,Ltd. (300395.SZ), Fujian Cosunter Pharmaceutical Co.,Ltd., and Eoptolink Technology Inc.,Ltd. (300502.SZ) have total market caps positioned above the historical 99th percentile, approaching or reaching historical peaks.
However, behind the soaring stock prices, performance among high-priced stocks shows polarization.
Taking Brightgene Bio-Medical Technology Co.,Ltd. as an example, the company's Q1 revenue was 250 million yuan, down 26.81% year-over-year; net profit was 13 million yuan, down 79.77% year-over-year; non-recurring net profit was only 8.03 million yuan, plunging 87.49% year-over-year. Northern Longbow's situation is more severe – post-listing performance has continued declining, with 2024 and Q1 2025 non-recurring net profits showing respective losses of 15.95 million yuan and 6.26 million yuan.
Meanwhile, some technology hundred-yuan stocks have achieved explosive performance growth. For instance, Cambricon Technologies Corporation Limited's Q1 2025 operating revenue reached 1.111 billion yuan, up 4,230.22% year-over-year, primarily benefiting from accelerated AI application deployment and market expansion. Net profit of 355 million yuan in the same period marked the first quarterly profit since listing, offsetting nearly 80% of 2024's full-year net loss. Eoptolink Technology Inc.,Ltd.'s performance guidance shows expected H1 net profit of 3.7-4.2 billion yuan, representing year-over-year growth of 327.68%-385.47%.
Comments